STALE?Report written 4 days ago · at $101.65entry levels may be stale — re-check before acting
RKLB
SpeculativeLARGE CAP
Rocket Lab USA, Inc. · NASDAQ · Space / Defense Technology
$101.65
▲ 4.50%
MCap $57.5B
Down 32% from May ATH $150 — Iridium $8B acquisition announced Jun 29 reshapes the entire investment thesis
BusinessSpace launch + satellite systems · Iridium acquisition ($8B) transforms into vertically-integrated operator · Neutron maiden launch Q4 2026 · $2.2B backlog
Thesis
Rocket Lab announced an $8B acquisition of Iridium on June 29, transforming from a pure-play launch company into a vertically-integrated satellite operator with 66 LEO satellites, L-band spectrum, and 2.55M subscribers. Combined with the Q4 2026 Neutron maiden launch window (FAA permit filed Jul 1–Dec 31), this is the most structurally significant catalyst in company history. Q2 earnings Aug 6 is the near-term catalyst; KeyBanc $135 target = +33% upside from a 32% pullback.
📝 Primary Verdict · Core Holding
BUYSpeculative
Buy the Iridium transformation dip — the acquisition repositions RKLB from a launch play to a full-stack space operator with captive launch demand, L-band spectrum, and 2.55M subscribers. Neutron success in Q4 = moon case unlocked.
94
score / 100 ⓘ
⚡ Catalyst
🛰️ Iridium $8B Acquisition — Space Operator TransformationANNOUNCED
Rocket Lab to acquire Iridium for $8B (cash + stock). Gains 66-satellite LEO network, L-band spectrum (only player globally), 2.55M subscribers. Transforms RKLB from launch company to full-stack space operator. Close expected mid-2027.
Jun 29, 2026
🚀 Neutron Maiden LaunchQ4 2026
FAA launch window filed: July 1 – December 31, 2026. Medium-lift partially-reusable rocket. Q4 2026 most likely timing. Binary event: success = +20–40% re-rate; failure = -25–35% drawdown.
Q4 2026
📊 Q2 2026 Earnings36 DAYS
Revenue guided $225–240M (+63% YoY midpoint). Q1 beat sent stock +34% on the day. Watch Neutron production update and Iridium deal timeline at the call.
Aug 6, 2026
🎖️ $816M SDA Satellite ConstellationEXECUTING
Build 18 satellites for Space Development Agency missile-defense constellation. Multi-year revenue anchor through 2028.
Dec 2025
🎯 Entry Point
Entry 1
$102.00
Current — 32% off ATH, Iridium deal-shock entryNow (small)
Entry 2PREFERRED
$88–95
Add zone if Iridium dilution fear spikes or Neutron delay newsOn any dip
Entry 3
$72.00
Neutron delay + Iridium approval risk worst caseDeep dip only
Below Jun lows = Iridium deal collapsing or Neutron indefinite delay
$83
-18%
Hard Stop
Neutron maiden failure + Iridium shareholder block
$65
-36%
Risk / Reward
Tight stop vs TP2
2.9 : 1
⚠ Size small 3–4% — binary Neutron risk demands smaller position
📅 Estimate Date
Q2 2026 Earnings
Revenue guide $225–240M; watch Neutron pad timeline + Iridium close update
Aug 6, 2026
est. $230M rev
Neutron FAA Launch Window
FAA Part 450 review complete; Q4 2026 most likely for maiden flight
Jul 1 – Dec 31, 2026
Q4 2026
📈 Stock Timeline
4 snapshots · Jun 22 → Jul 1
Score
▼ 2
72
Jun 22Jul 1
TP2 Target
▼ 6
$155
Jun 22Jul 1
Rank
▲ 4
#2
Jun 22Jul 1
📈 Possible Up % — Scenario Spread
Bear
-36%
$65
Base
+23%
$125
Bull
+53%
$155
Moon
+97%
$200
← downsideupside →
🏛️ Fed / Macro Risk — LOW
Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution
Rate Outlook
Fed at 3.50–3.75%; space/defense revenue (HASTE, SDA, Space Force) is government-contract backed — not rate sensitive. Iridium L-band is essential infrastructure.
Inflation
Core PCE 3.4%; defense contracts have inflation adjustment clauses. Rocket propellant and manufacturing costs are the primary inflation exposure.
Sector Impact
Space sector driven by government spending and commercial demand — largely decoupled from Fed rate cycle. Iran conflict = accelerated DoD spending = net positive for RKLB defense book.
Summary
LOW — government contract base insulates from rate risk. Primary risks are execution (Neutron) and balance sheet (Iridium debt), not macro.
🎯 Analyst Targets
Wall Street price targets vs the current price — cross-check our TP levels
KeyBanc (Overweight)
Overweight$135+33%
Analyst Consensus (27 analysts)
Buy$104+2%
High target
Buy$150+48%
Low target
Hold$60-41%
current price $101.65
🔍 Similar-Catalyst Comparable Check
Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic
RKLB✅ GoodMay 2026
+34%
in 1 day
Q1 2026 Earnings Beat + $2.2B Backlog
Q1 2026 earnings produced a +34% single-session move on revenue +63.5% YoY + backlog doubling +108% YoY. Q2 2026 sets up a similar beat given $225–240M guidance with strong government contract flow.
SPCE✅ GoodJul 2021
+30%
in 5 days
First successful commercial spaceflight — July 2021
Virgin Galactic +30% in 5 days after first successful commercial spaceflight — comparable to Neutron maiden success re-rating thesis for RKLB as the second viable commercial medium-lift launch provider.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode
Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.
⚠️
Use this stop-loss set (-18% / -25%) only when trading the earnings spot — not for the core holding (use the -18% / -36% set above). If you are holding long-term, follow the core set.
📈Pre-Catalyst Run-up Pattern
+15–30%Jul 1 → Aug 6 (earnings); then Oct–Dec (Neutron window)
Rocket Lab historically rallies 15–30% in the 4–6 weeks before a confirmed launch window opens, driven by investor anticipation and contract announcement cadence. Iridium deal creates a new pre-catalyst entry narrative.
🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +20%
range: +10% to +40%· May 2026
Q1 2026 earnings beat sent stock +34% in a single session. Neutron maiden success historically comparable to SpaceX Falcon 9 first reuse — sector re-rating catalyst (+20–40% in the week after).
❌ Catalyst Missavg -25%
range: -15% to -35%· Jun 2026
Neutron failure = -25–35% in the week after. Prior Neutron delay headlines caused -10–20% drawdowns. SpaceX IPO rotation caused -10%.
💼Spot Position Sizing
How the recommended % is derived
4%
of portfolio
High conviction on Iridium transformation + Neutron binary upside, but execution risk is real. Limit to 3–4% of portfolio. Scale in on dips pre-Neutron window.
🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-18%($83)
Below Jun lows = Iridium deal collapsing or Neutron indefinitely delayed
After Catalyst (Bad Result)-25%
Neutron failure = exit all within 2 sessions; do not average down on vehicle loss